Presented by N.P.Vasavan Nair, MD, FRCPC, Medical Chief, Program for Dementia with Psychiatric Co-morbidity

A vaccine-based approach could be an effective therapy for people with mild or moderate form of Alzheimer's disease. The medication used for this therapy will be tested at the Douglas Mental Health University Institute, starting in 2009, participating in an international effort to find out more about the potential of this treatment. Most current therapies for Alzheimer's treat the symptoms associated with it and not the disease itself. The goal with this clinical trial is to explore if this investigational drug can help control the progression of Alzheimer's by eliminating the protein that cause damage to the brain.

Tweet